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Abstract
Background: Timing and adequacy of peritoneal source control are the most important pillars in the management
of patients with acute peritonitis. Therefore, early prognostic evaluation of acute peritonitis is paramount to assess
the severity and establish a prompt and appropriate treatment. The objectives of this study were to identify clinical
and laboratory predictors for in-hospital mortality in patients with acute peritonitis and to develop a warning score
system, based on easily recognizable and assessable variables, globally accepted.
Methods: This worldwide multicentre observational study included 153 surgical departments across 56 countries
over a 4-month study period between February 1, 2018, and May 31, 2018.
Results: A total of 3137 patients were included, with 1815 (57.9%) men and 1322 (42.1%) women, with a median
age of 47 years (interquartile range [IQR] 28–66). The overall in-hospital mortality rate was 8.9%, with a median
length of stay of 6 days (IQR 4–10). Using multivariable logistic regression, independent variables associated with in-
hospital mortality were identified: age > 80 years, malignancy, severe cardiovascular disease, severe chronic kidney
disease, respiratory rate ≥ 22 breaths/min, systolic blood pressure < 100 mmHg, AVPU responsiveness scale (voice
and unresponsive), blood oxygen saturation level (SpO2) < 90% in air, platelet count < 50,000 cells/mm3, and
lactate > 4 mmol/l. These variables were used to create the PIPAS Severity Score, a bedside early warning score for
patients with acute peritonitis. The overall mortality was 2.9% for patients who had scores of 0–1, 22.7% for those
who had scores of 2–3, 46.8% for those who had scores of 4–5, and 86.7% for those who have scores of 7–8.
Conclusions: The simple PIPAS Severity Score can be used on a global level and can help clinicians to identify
patients at high risk for treatment failure and mortality.
Keywords: Acute peritonitis, Source control, Early warning score, Emergency surgery
Introduction
Peritonitis is an inflammation of the peritoneum. De-
pending on the underlying pathology, it can be infec-
tious or sterile [1]. Infectious peritonitis is classified into
primary peritonitis, secondary peritonitis, and tertiary
peritonitis. Primary peritonitis is a diffuse bacterial infec-
tion (usually caused by a single organism) without loss
of integrity of the gastrointestinal tract, typically seen in
cirrhotic patients with ascites or in patients with a
peritoneal dialysis catheter. It has a low incidence in sur-
gical wards and is usually managed without any surgical
intervention. Secondary peritonitis is an acute peritoneal
infection resulting from loss of integrity of the gastro-
intestinal tract. Tertiary peritonitis is a recurrent
infection of the peritoneal cavity that occurs > 48 h after
apparently successful and adequate surgical source con-
trol of secondary peritonitis. Secondary peritonitis is the
most common form of peritonitis. It is caused by per-
foration of the gastrointestinal tract (e.g. perforated
duodenal ulcer) by direct invasion from infected intra-
abdominal viscera (e.g. gangrenous appendicitis). It is an
important cause of patient morbidity and is frequently
associated with significant morbidity and mortality rates
[2], despite development in diagnosis and management.
Timing and adequacy of peritoneal source control are
the most important pillars in the management of pa-
tients with acute peritonitis, being determinant to con-
trol or interrupt the septic process [2, 3].
Many peritonitis-specific scoring systems have been
designed and used to grade the severity of acute periton-
itis [4–7].
Patients with acute peritonitis are generally classified
into low risk and high risk. “High risk” is generally
intended to describe patients at high risk for treatment
failure and mortality [6]. In high-risk patients, the in-
creased mortality associated with inappropriate manage-
ment cannot be reversed by subsequent modifications.
Therefore, early prognostic evaluation of acute peritonitis
is important to assess the severity and decide the aggres-
siveness of treatment. Moreover, in emergency depart-
ments of limited-resource hospitals, diagnosis of acute
peritonitis is mainly clinical, and supported only by basic
laboratory tests [8], making some scoring systems imprac-
tical to a large part of the world’s population.
The objectives of this study were (a) to identify all
clinical and laboratory predictors for in-hospital mortal-
ity in patients with acute peritonitis and (b) to develop a
warning score system, based on easily recognizable and
assessable variables, globally accepted, so as to provide
the clinician with a simple tool to identify patients at
high risk for treatment failure and mortality.
Methods
Study population
This worldwide multicentre observational study was
performed across 153 surgical departments from 56
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countries over a 4-month study period (February 1, 2018
– May 31, 2018). All consecutive patients admitted to
surgical departments with a clinical diagnosis of acute
peritonitis were included in the study. The following
data were collected: age and gender; presence of comor-
bidities, namely primary or secondary immunodeficiency
(chronic treatment with glucocorticoids, with immuno-
suppressive agents or chemotherapy, and patients with
lymphatic diseases or with virus-related immunosup-
pression; solid or haematopoietic and lymphoid malig-
nancy; severe cardiovascular disease (medical history of
ischemic heart disease, history of heart failure, severe
valvular disease [9]); diabetes with or without organ dys-
function; severe chronic kidney disease; and severe
chronic obstructive pulmonary disease (COPD) [10].
Clinical findings were recorded at admission: abdominal
findings (localized or diffuse abdominal pain, localized
or diffuse abdominal rigidity); core temperature (defining
fever as core temperature > 38.0 °C, and hypothermia as
core temperature < 36.0 °C); heart rate (bpm); respira-
tory rate (breaths/min); systolic blood pressure (mmHg);
alert/verbal/painful/unresponsive (AVPU) responsiveness
scale [11]; and numerical rating scale (NRS) [12].
The following laboratory findings were also collected:
blood oxygen saturation level (SpO2) (%) in air, white blood
count (WBC) (cells/mm3), platelet count (cells/ mm3),
international normalised ratio (INR), C-reactive protein
(CRP) (mg/l), procalcitonin (ng/ml), and lactate (mmol/l).
Quick Sequential Organ Failure Assessment (qSOFA)
score upon admission was calculated [13]. The modality
and setting of acquisition of radiological investigations
(abdominal x-ray, ultrasound [US], computer tomography
[CT] scan) was specified. Peritonitis was classified as
community-acquired or healthcare-acquired. Peritonitis
was considered healthcare-associated in patients hospital-
ized for at least 48 h during the previous 90 days; or those
residing in skilled nursing or long-term care facility during
the previous 30 days; or those who have received intraven-
ous therapy, wound care, or renal replacement therapy
within the preceding 30 days. Source of infection, extent of
peritonitis (generalized or localized peritonitis/abscess),
source control (conservative treatment, operative or non-
operative interventional procedures), and its adequacy
were noted. The adequacy of the intervention was defined
by the establishment of the cause of peritonitis and the
ability to control the source of the peritonitis [14]. Delay in
the initial intervention (> 24 h of admission), and adequacy
of antimicrobial therapy (if guided by antibiograms per-
formed) were assessed. Reoperation during the hospital
stay, re-laparotomy strategy (open abdomen, planned re-
laparotomy, on demand re-laparotomy) and its timing,
immediate (within 72 h) infectious post-operative compli-
cations, delayed infectious post-operative complications,
length of hospital stay (LOS), and in-hospital mortality
were determined. All patients were monitored until they
were discharged or transferred to another facility.
Study design
The centre coordinator of each participating medical insti-
tution collected data in an online case report database.
Differences in local surgical practice of each centre were
respected, and no changes were impinged on local man-
agement strategies. Each centre followed its own ethical
standards and local rules. The study was monitored by a
coordinating centre, which processed and verified any
missing or unclear data submitted to the central database.
The study did not attempt to change or modify the clinical
practice of the participating physicians. Accordingly, in-
formed consent was not needed and each hospital
followed their ethical rules for formal research including
an ethical approval if approval was needed. The data were
completely anonymised. The study protocol was approved
by the board of the World Society of Emergency Surgery
(WSES), and the study was conducted under its supervi-
sion. The board of the WSES granted the proper ethical
conduct of the study. The study met and conformed to
the standards outlined in the Declaration of Helsinki and
Good Epidemiological Practices.
Statistical analysis
The data were analysed in absolute frequency and percent-
age, in the case of qualitative variables. Quantitative vari-
ables were analysed as medians and interquartile range
(IQR). Univariate analyses were performed to study the as-
sociation between risk factors and in-hospital mortality
using a chi-square test, or a Fisher’s exact test, if the ex-
pected value of a cell was < 5. All tests were two-sided, and
p values of 0.05 were considered statistically significant.
To identify independent risk factors associated with
in-hospital mortality, a multivariable logistic regression
analysis was performed selecting independent variables
that had p value < 0.05 in the univariate analysis. Then,
a backward selection method was applied to select a lim-
ited number of variables, using a likelihood ratio test for
comparing the nested models (α = 0.05). At each step,
we removed from the previous model the variable with
the highest p value greater than α, checking the fit of the
obtained model, and then stopping when all p values
were less than α. Then, we checked the global perform-
ance of the test calculating the area under the receiver
operating characteristic (ROC) curve. All statistical ana-
lyses were performed using the Stata 11 software pack-
age (StataCorp, College Station, TX).
Results
Patients and diagnosis
During the study, 3137 patients from 153 hospitals
worldwide were collected; these included 1815 (57.9%)
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men and 1322 (42.1%) women, with a median age of
47 years (IQR, 28–66). Considering World Health
Organization regions, 1981 (63.1%) patients were collected
in countries belonging to European region, 396 (12.6%)
patients were from the African region, 275 (8.8%) from
the region of the Americas, 239 (7.6%) from the
South-East Asia region, 173 (5.5%) from the Eastern-
Mediterranean region, and 73 (2.3%) from the Western
Pacific region.
Forty-one (1.3%) patients were asymptomatic, while
990 (31.6%) reported localized abdominal pain, 665
(21.2%) localized abdominal rigidity, 797 (25.4%) diffuse
abdominal pain, and 592 (18.9%) diffuse abdominal rigid-
ity. In 52 (1.7%) patients, abdominal findings were not re-
ported. Three hundred and thirty (10.5%) patients
underwent abdominal x-ray, 756 (24.1%) patients had an
US, 1016 (32.4%) abdominal CT scan, 189 (6.0%) patients
had both abdominal x-ray and US, 76 (2.4%) had both ab-
dominal x-ray scan and CT, 199 (6.3%) patients had both
CT scan and US, 93 (3.0%) patients underwent abdominal
x-ray scan, US and CT, and 445 (14.3%) patient did not
undergo any radiological investigation. In 33 (1.1%) pa-
tients, radiological diagnosis was not specified.
Considering the setting of acquisition, 2826 (90.1%)
patients were affected by community-acquired intra-
abdominal infections (IAIs), while the remaining 311
(9.9%) suffered from healthcare-associated IAIs; moreover,
1242 patients (39.6%) were affected by generalized peri-
tonitis, while 1895 (60.4%) suffered from localized periton-
itis or abscesses. The cause of infection was acute
appendicitis in 1321 (42.1%) patients, acute cholecystitis
in 415 (13.2%), gastroduodenal perforation in 364 (11.6%)
patients, small bowel perforation in 219 (7.0%), acute
diverticulitis in 217 (6.9%), colonic perforation in 203
(6.5%), post-traumatic perforation in 79 (2.5%), acute in-
fected pancreatitis in 40 (1.3%), pelvic inflammatory dis-
ease (PID) in 30 (1.0%), and other causes in 249 (7.9%).
Management
Among all patients enrolled in the PIPAS Study, 377
(12%) underwent non-operative procedures, and the
other 2760 (88.0%) patients underwent operative inter-
ventional procedures as first-line treatment. Source con-
trol was considered inadequate in 247 (247/2834, 8.7%)
patients who underwent surgical procedures. In 1630
(1630/2834, 57.5%) patients the initial intervention was
delayed. Among 2159 patients who received antimicro-
bial therapy, in 336 (15.6%), it was considered inad-
equate. During the same hospitalization, 242 (242/2760,
8.8%) patients underwent a second procedure after 4
(IQR 2–7) days because of a postoperative complication
or a worsening of the initial stage. In particular, 79
(2.9%) patients underwent an open abdomen surgery, 57
(2.1%) a planned relaparotomy, and 87 (3.2%) an on-
demand relaparotomy, and in 19 (0.7%) patients, no spe-
cific procedure was specified.
Immediate post-operative complications were ob-
served in 339 (339/2760, 12.3%) patients who underwent
a surgical procedure; among them we observed ongoing
peritonitis in 174 (6.3%) patients, multi-organ failure in
33 (1.2%), bleeding in 32 (1.2%), cardiovascular compli-
cations in 17 (0.6%), respiratory complications in 15
(0.5%), sepsis or septic shock in 13 (0.5%), and other
complications in 55 (2.0%). Delayed post-operative com-
plications were detected in 774 (774/2760, 28.0%) pa-
tients who underwent an interventional procedure; in
particular, they suffered from surgical site infections in
343 (12.4%) patients, post-operative peritonitis in 132
(4.8%), post-operative abdominal abscess in 118 (4.3%),
respiratory complications in 54 (2.0%),cardiovascular
complications in 39 (1.4%), sepsis or septic shock in 33
(1.2%), ileus in 22 (0.8%), multi-organ failure in 18
(0.7%), renal complications in 13 (0.5%), and other com-
plications in 79 (2.9%).
Outcome
The overall in-hospital mortality rate was 8.9%. The me-
dian duration of hospitalization was 6 days (IQR 4–10).
Bivariate analyses were performed to analyse the associ-
ation between risk factors and in-hospital mortality
using a two-sided chi-square test or a two-sided Fisher’s
exact test where appropriate. Distribution of clinical pre-
dictive variables of in-hospital mortality is reported in
Table 1. Distribution of laboratory predictive variables of
in-hospital mortality is reported in Table 2.
Independent variables associated with in-hospital mor-
tality according to the multivariable logistic regression
are reported in Table 3. The model was highly significant
(p < 0.0001), and the global performance of the test is
explained by the area under the ROC curve, which is
equals to 0.84 (95% CI).
Developing the severity score
The second aim of the study was to develop a severity
score for patients with a clinical diagnosis of acute peri-
tonitis that is simple and globally acceptable with a good
prognostic value. Only the significant clinical variables
associated with in-hospital mortality obtained from the
multivariable logistic regression model were included,
excluding the lactate, and platelet count. This modifica-
tion was done for three reasons: (a) to simplify the score,
(b) to make it more universal and globally acceptable,
and (c) because of lack of facilities to obtain lactate in
low-income countries. The coefficients of the variables
were used to develop the score, and not the Odds Ratio.
The significant clinical variables were subjected to
different direct logistic regression models using either
simple binomial variables or ordinal data, to arrive at a
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Table 1 Distribution of clinical predictive variables of in-hospital mortality
Variables Total patients Dead Survivors RR p value
n 3137 n 280 n 2857
(100%) (8.9%) (91.1%)
Age > 80 years 246 (7.8) 72 (25.7) 174 (6.1) 4.07 (3.22–5.14) < 0.001
Immunodeficiency 240 (7.7) 56 (20.0) 184 (6.4) 3.02 (2.32–3.92) < 0.001
Malignancy 333 (10.6) 83 (29.6) 250 (8.8) 3.55 (2.82–4.46) < 0.001
Severe cardiovascular disease 406 (12.9) 106 (37.9) 300 (10.5) 4.10 (3.30–5.10) < 0.001
Diabetes 400 (12.8) 76 (27.1) 324 (11.3) 2.55 (2.00–3.25) < 0.001
Severe CKD 141 (4.5) 52 (18.6) 89 (3.1) 4.85 (3.78–6.22) < 0.001
Severe COPD 186 (5.9) 60 (21.4) 126 (4.4) 4.33 (3.39–5.52) < 0.001
Core temperature (°C)
< 36.0 85 (2.7) 23 (8.2) 62 (2.2) 3.21 (2.22–4.64) < 0.001
36.0–38.0 2292 (73.1) 185 (66.1) 2107 (73.7) 0.72 (0.57–0.91) < 0.05
> 38.0 760 (24.2) 72 (25.7) 688 (24.1) 1.08 (0.84–1.40) 0.54
Hearth rate (bpm)
< 60 8 (0.3) 1 (0.4) 7 (0.2) 1.40 (0.22–8.80) 0.72
60–100 1919 (61.2) 117 (41.8) 1802 (63.1) 0.46 (0.36–0.57) < 0.001
> 100 1210 (38.6) 162 (57.9) 1048 (36.7) 2.19 (1.74–2.74) < 0.001
Systolic blood pressure (mmHg)
< 90 138 (4.4) 49 (17.5) 89 (3.1) 4.61 (3.57–5.96) < 0.001
90–100 388 (12.4) 70 (25.0) 318 (11.1) 2.36 (1.84–3.03) < 0.001
> 100 2610 (83.2) 161 (57.5) 2449 (85.7) 0.27 (0.22–0.34) < 0.001
Respiratory rate (breaths/min)
< 22 2244 (71.5) 124 (44.3) 2120 (74.2) 0.32 (0.25–0.40) < 0.001
22–29 684 (21.8) 97 (34.6) 587 (20.5) 1.90 (1.50–2.39) < 0.001
30–35 154 (4.9) 39 (13.9) 115 (4.0) 3.13 (2.33–4.21) < 0.001
> 35 55 (1.8) 20 (7.1) 35 (1.2) 4.31 (2.98–6.23) < 0.001
AVPU responsiveness scale
Alert 2917 (93.0) 187 (66.8) 2730 (95.6) 0.15 (0.12–0.19) < 0.001
Voice 123 (3.9) 54 (19.3) 69 (2.4) 5.85 (4.62–7.41) < 0.001
Pain 74 (2.4) 23 (8.2) 51 (1.8) 3.70 (2.59–5.30) < 0.001
Unresponsive 23 (0.7) 16 (5.7) 7 (0.2) 8.21 (6.12–11.01) < 0.001
NRS
0–3 80 (2.6) 16 (5.7) 64 (2.2) 2.32 (1.47–3.64) < 0.001
4–6 1512 (48.2) 112 (40.0) 1400 (49.0) 0.72 (0.57–0.90) < 0.05
7–10 1112 (35.4) 128 (45.7) 984 (34.4) 1.53 (1.23–1.92) < 0.001
Not reported 433 (13.8) 24 (8.6) 409 (14.3) NA NA
qSOFA score
0 1367 (43.6) 37 (13.2) 1330 (46.6) 0.20 (0.14–0.28) < 0.001
1 1323 (42.2) 109 (38.9) 1214 (42.5) 0.87 (0.96–1.10) 0.25
2 353 (11.3) 84 (30.0) 269 (9.4) 3.38 (2.68–4.26) < 0.001
3 94 (3.0) 50 (17.9) 44 (1.5) 7.04 (5.61–8.82) < 0.001
All p values calculated using two-sided chi-square test
RR: risk ratio, NA: not applicable, CKD: chronic kidney disease, COPD: chronic obstructive pulmonary disease, AVPU: alert/verbal/painful/unresponsive, NRS:
numerical rating scale, qSOFA: Quick Sequential Organ Failure Assessment
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simplified and acceptable model. Direct logistic regres-
sion model of the clinical variables affecting mortality
which were used to develop the score is reported in
Table 4. The score would have become complicated if
we had to follow the model proposed by Moons et al.
[15], whereby the coefficient would have to be multiplied
by 10 and the value approximated to the nearest integral
to get a score. This meant that the scores derived from
Table 2 Distribution of laboratory predictive variables of in-hospital mortality
Variables Total patients Dead Survivors RR p value
n 3137 n 280 n 2857
(100%) (8.9%) (91.1%)
Blood oxygen saturation level (SpO2) (%) in air
> 92 2782 (88.7) 152 (54.3) 2630 (92.1) 0.15 (0.12–0.19) < 0.001
90–91 198 (6.3) 66 (23.6) 132 (4.6) 4.58 (3.62–5.79) < 0.001
85–89 99 (3.1) 41 (14.6) 58 (2.0) 5.26 (4.04–6.85) < 0.001
< 85 21 (0.7) 9 (3.2) 12 (0.4) 4.93 (2.97–8.18) < 0.001
Not reported 37 (1.2) 12 (4.3) 25 (0.9) NA NA
WBC (cells/mm3)
> 12,000 1950 (62.2) 182 (65.0) 1768 (61.9) 1.13 (0.89–1.43) 0.30
4000–12,000 1043 (33.2) 63 (22.5) 980 (34.3) 0.58 (0.44–0.76) < 0.001
< 4000 94 (3.0) 29 (10.4) 65 (2.3) 3.74 (2.70–5.18) < 0.001
Not reported 50 (1.6) 6 (2.1) 44 (1.5) NA NA
Platelet count (cells/ mm3)
> 150,000 2606 (83.1) 183 (65.4) 2423 (84.8) 0.38 (0.31–0.49) < 0.001
50,000–1,500,000 387 (12.3) 73 (26.1) 314 (11.0) 2.51 (1.96–3.20) < 0.001
< 50,000 32 (1.0) 18 (6.4) 14 (0.5) 6.67 (4.81–9.24) < 0.001
Not reported 112 (3.6) 6 (2.1) 106 (3.7) NA NA
INR
> 3 23 (0.7) 12 (4.3) 11 (0.4) 6.06 (4.03–9.11) < 0.001
1.2–3 296 (9.4) 72 (25.7) 224 (7.8) 3.32 (2.61–4.22) < 0.001
< 1.2 1954 (62.3) 149 (53.2) 1805 (63.2) 0.69 (0.55–0.86) 0.001
Not reported 864 (27.5) 47 (16.8) 817 (28.6) NA NA
CRP (mg/l)
> 200 450 (14.3) 70 (25.0) 380 (13.3) 1.99 (1.55–2.56) < 0.001
101–200 462 (14.7) 51 (18.2) 411 (14.4) 1.29 (0.97–1.72) 0.08
5–100 946 (30.2) 69 (24.6) 877 (30.7) 0.76 (0.58–0.98) 0.04
< 5 258 (8.2) 3 (1.1) 255 (8.9) 0.12 (0.04–0.37) < 0.001
Not reported 1471 (46.9) 157 (56.1) 1314 (46.0) NA NA
Procalcitonin (ng/ml)
> 10 85 (2.7) 31 (11.1) 54 (1.9) 4.47 (3.30–6.06) < 0.001
0.5–10 260 (8.3) 42 (15.0) 218 (7.6) 1.96 (1.44–2.64) < 0.001
< 0.5 100 (3.2) 3 (1.1) 97 (3.4) 0.33 (0.11–1.01) 0.03
Not reported 2692 (85.8) 204 (72.9) 2488 (87.1) NA NA
Lactate (mmol/l)
>4 139 (4.4) 61 (21.8) 78 (2.7) 6.01 (4.79–7.54) < 0.001
1–4 615 (19.6) 86 (30.7) 529 (18.5) 1.82 (1.43–2.31) < 0.001
< 1 136 (4.3) 6 (2.1) 130 (4.6) 0.48 (0.22–1.07) 0.06
Not reported 2247 (71.6) 127 (45.4) 2120 (74.2) NA NA
All p values calculated using two-sided chi-square test
RR: risk ratio, NA: not applicable, WBC: white blood count, INR: international normalised ratio, CRP; C-reactive protein
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the model would be 10, 11, 9, 12, 8, 9, 9, and 14, making
it very complex. Hence, it was decided to approximate
the coefficient to the nearest integral number and test
the model. Since the coefficients were approximated to
1, each of these variables could have a score of 1 or 0
with a maximum score of 8 and a range of 0–8. The
simplified and finalized the PIPAS Severity Score is
shown in the Appendix.
The PIPAS Severity Score had a very good ability of
distinguishing those who survived from those who died
(Fig. 1). The ROC curve showed that the best cutoff
point for predicting mortality was a PIPAS Severity
Score of 1.5 having a sensitivity of 74.3%, a specificity of
82.2% (Fig. 2) and an area under the curve of 85.1%. The
overall mortality was 2.9% for the patients who had
scores of 0 and 1, 22.7% for those who had scores of 2
and 3, 46.8% for those who had scores 4 and 5, and
86.7% for those who have scores 7–8.
Discussion
Using the multivariable logistic regression, ten independent
variables associated with in-hospital mortality were
identified. The model was highly significant, with a good
global performance of the test. Excluding platelet count
and lactate, eight bedside easy-to-measure parameters were
recognized to develop an early warning score, the PIPAS
Severity Score, assessing anamnestic data (age > 80 years,
malignancy, severe cardiovascular disease, severe chronic
kidney disease), and physiological functions (respiratory
rate ≥ 22 breaths/min, systolic blood pressure < 100
mmHg, AVPU responsiveness scale voice or unresponsive,
blood oxygen saturation level (SpO2) < 90% in air).
The PIPAS Severity Score, taking into account physio-
logical parameters recognizable on hospital admission,
immediately allows clinicians to assess the severity and
decide the aggressiveness of treatment. Particularly for
clinicians working in low- and middle-income countries,
where diagnostic imaging is often insufficient, and in
some instances completely lacking, the utility of this
score system is remarkable [16].
Sometimes, the atypical clinical presentation of acute
peritonitis may be responsible for a delay in diagnosis and
treatment. Therefore, a triage system that quickly recog-
nizes patients at high risk for mortality and allows to
Table 3 Results of multinomial logistic regression for the analysis of variables associated with in-hospital mortality
Variables OR 95% CI p value
Age > 80 years 2.11 1.43–3.10 < 0.001
Malignancy 3.02 2.15–4.24 < 0.001
Severe cardiovascular disease 2.76 1.97–3.87 < 0.001
Severe chronic kidney disease 3.33 2.12–5.23 < 0.001
Respiratory rate ≥ 22 breaths/min 3.38 2.23–5.13 < 0.001
Systolic blood pressure < 100mmHg 2.18 1.58–3.00 < 0.001
AVPU responsiveness scale voice or unresponsive 3.07 2.10–4.51 < 0.001
Blood oxygen saturation level (SpO2) < 90% in air 2.67 1.64–4.32 < 0.001
Platelet count < 50,000 cells/ mm3 4.81 2.07–11.20 < 0.001
Lactate > 4mmol/l 4.00 2.58–6.23 < 0.001
CI: confidence interval, OR: odds ratio, AVPU: alert/verbal/painful/unresponsive
Table 4 Direct logistic regression model with clinical variables affecting mortality of patients used to develop the score
Variable Estimate SE Wald
test
P OR 95% CI
LL UL
Age > 80 years 0.97 0.19 25.91 < 0.0001 2.63 1.81 3.89
Malignancy 1.13 0.17 42.43 < 0.0001 3.11 2.21 4.37
Severe CVD 0.88 0.17 26.09 < 0.0001 2.41 1.72 3.38
Severe CKD 1.2 0.23 26.23 < 0.0001 3.32 2.1 5.26
RR ≥ 22 breaths/min 0.75 0.16 22.61 < 0.0001 2.11 1.55 2.87
SBP < 100mmHg 0.86 0.17 27.29 < 0.0001 2.37 1.71 3.27
AVPU responsiveness scale: not completely alert. 1.35 0.2 47.98 < 0.0001 3.86 2.63 5.65
Blood oxygen saturation level: SpO2 < 90% in air 0.87 0.25 12.15 < 0.0001 2.39 1.46 3.89
Constant − 3.79 0.13 834.77 < 0.0001 0.023 – –
SE: standard error, OR: odds ratio, CI: confidence interval, LL: lower limit, UL: upper limit, CVD: cardiovascular disease, CKD: chronic kidney disease, RR: respiratory
rate, SBP: systolic blood pressure, AVPU: alert/verbal/painful/unresponsive
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transfer them immediately to an acute care unit is a vital
component of the emergency services. As a consequence,
any process of improving the quality of emergency care
globally should focus on simple diagnostic criteria based
on physical examination findings that can recognize pa-
tients needing critical care. From a global perspective, a
feasible, low-cost method of rapidly identifying patients
requiring critical care is crucial. Early warning system
scores utilize physiological, easy-to-measure parameters,
assessing physiological parameters such as systolic blood
pressure, pulse rate, respiratory rate, temperature, oxygen
saturations, and level of consciousness [17].
The statistical analysis shows that the PIPAS Severity Score
has a very good ability of distinguishing those who survived
from those who died. The overall mortality was 2.9% for the
patients who had scores of 0 and 1, 22.7% for those who had
scores of 2 and 3, 46.8% for those who had scores of 4 and 5,
and 86.7% for those who have scores of 7–8.
PIPAS Study has strengths and limitations. It is an
observational multicentre study involving a large, but
probably not representative, number of hospitals world-
wide, since the majority of patients were collected in
countries belonging to the WHO European region. More-
over, its validity needs to be tested in future large pro-
spective series before potentially serving as a template for
future database and research into patient outcomes.
Finally, a potential limitation may be the high rate of
patients with acute appendicitis enrolled in the study
(42.1%). Some authors [18], after excluding patients with
perforated appendicitis, found that the cure rate among
patients who had peritonitis and were enrolled in clinical
trials, was much higher than that of patients who were
not enrolled and that the mortality rate was much lower.
Although, delineating the source of infection as accurately
as possible prior to surgery is described as the primary
aim and the first step in managing acute peritonitis, in
emergency departments of limited-resource hospitals,
diagnosis of acute peritonitis is mainly clinical, and sup-
ported only by basic laboratory tests, and excluding acute
appendicitis in the pre-operative phase would make the
score impractical to a large part of the world’s population.
Conclusions
This worldwide multicentre observational study was per-
formed in 153 surgical departments from 56 countries over
a 4-month study period (February 1, 2018–May 31, 2018).
All consecutive patients admitted to surgical departments
with clinical diagnosis of acute peritonitis were included in
the study. The most significant independent variables asso-
ciated with in-hospital mortality were adjusted to clinical
criteria and were used to create a new bedside early warn-
ing score for patients with acute peritonitis. The simple
PIPAS Severity Score for patients with acute peritonitis can
be used on the global level and can help clinicians to assess
patients with acute peritonitis at high risk for treatment
failure and mortality. The authors created an acronym for
the PIPAS Severity Score to help remember the variables
“Scores Must Be Simple For Sepsis Risk Assessment”
(severe cardiovascular disease, malignancy, blood oxygen
saturation level, severe chronic kidney disease, fully alert,
systolic blood pressure, respiratory rate, age).
Fig. 1 Distribution of the percentile PIPAS Severity Score of hospitalized
peritonitis patients for those who survived (continuous line) (n = 2832)
and those who died (interrupted line) (n = 268). Global data from 153
worldwide surgical departments in 56 countries, over a 4-month study
period (February 1, 2018–May 31, 2018). Thirty-seven patients (1.2%) had
missing data in whom the score could not be computed
Fig. 2 Receiver operating characteristic (ROC) curve for the best
PIPAS Severity Score (1.5, black circle) that predicted mortality
in peritonitis patients. Global data from 153 worldwide surgical
departments in 56 countries, over a 4-month study period
(February 1, 2018–May 31, 2018)
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